ESR2 and prostate cancer: For example, the loss of estrogen beta manifestation shows a relationship, with amplified propagation in the “ERβ KO/transgenic adenocarcinoma of mouse prostate classic” [92] and human prostate cancer specimens [80, 93, 94].